Irritable Bowel Syndrome with Diarrhea Drugs and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Sales Channel
1.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Overall Market Size
2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size: 2022 VS 2029
2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Players in Global Market
3.2 Top Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Companies Ranked by Revenue
3.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Companies
3.4 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Companies
3.5 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Players in Global Market
3.8.1 List of Global Tier 1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Markets, 2022 & 2029
4.1.2 XIFAXAN
4.1.3 Viberzi
4.1.4 Lotronex
4.1.5 Other
4.2 By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue & Forecasts
4.2.1 By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, 2018-2023
4.2.2 By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, 2024-2029
4.2.3 By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales & Forecasts
4.3.1 By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, 2018-2023
4.3.2 By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, 2024-2029
4.3.3 By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Sales Channel
5.1 Overview
5.1.1 By Sales Channel - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2022 & 2029
5.1.2 Hospitals Pharmacy
5.1.3 Retail Pharmacy
5.1.4 Other
5.2 By Sales Channel - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue & Forecasts
5.2.1 By Sales Channel - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, 2018-2023
5.2.2 By Sales Channel - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, 2024-2029
5.2.3 By Sales Channel - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share, 2018-2029
5.3 By Sales Channel - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales & Forecasts
5.3.1 By Sales Channel - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, 2018-2023
5.3.2 By Sales Channel - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, 2024-2029
5.3.3 By Sales Channel - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share, 2018-2029
5.4 By Sales Channel - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2022 & 2029
6.2 By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue & Forecasts
6.2.1 By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, 2018-2023
6.2.2 By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, 2024-2029
6.2.3 By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales & Forecasts
6.3.1 By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, 2018-2023
6.3.2 By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, 2024-2029
6.3.3 By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, 2018-2029
6.4.2 By Country - North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, 2018-2029
6.4.3 US Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.4.4 Canada Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.4.5 Mexico Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, 2018-2029
6.5.3 Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.5.4 France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.5.5 U.K. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.5.6 Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.5.7 Russia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.5.9 Benelux Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, 2018-2029
6.6.3 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.6.4 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.6.5 South Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.6.7 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, 2018-2029
6.7.2 By Country - South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, 2018-2029
6.7.3 Brazil Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.7.4 Argentina Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, 2018-2029
6.8.3 Turkey Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.8.4 Israel Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.8.6 UAE Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Bausch Health
7.1.1 Bausch Health Company Summary
7.1.2 Bausch Health Business Overview
7.1.3 Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Product Offerings
7.1.4 Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Bausch Health Key News & Latest Developments
7.2 Allergan
7.2.1 Allergan Company Summary
7.2.2 Allergan Business Overview
7.2.3 Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Product Offerings
7.2.4 Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Allergan Key News & Latest Developments
7.3 Sebela Pharmaceuticals
7.3.1 Sebela Pharmaceuticals Company Summary
7.3.2 Sebela Pharmaceuticals Business Overview
7.3.3 Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Product Offerings
7.3.4 Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Sebela Pharmaceuticals Key News & Latest Developments
7.4 Astellas Pharmaceuticals
7.4.1 Astellas Pharmaceuticals Company Summary
7.4.2 Astellas Pharmaceuticals Business Overview
7.4.3 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Product Offerings
7.4.4 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Astellas Pharmaceuticals Key News & Latest Developments
7.5 Amneal Pharms
7.5.1 Amneal Pharms Company Summary
7.5.2 Amneal Pharms Business Overview
7.5.3 Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Product Offerings
7.5.4 Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Amneal Pharms Key News & Latest Developments
7.6 Pharscin Pharma
7.6.1 Pharscin Pharma Company Summary
7.6.2 Pharscin Pharma Business Overview
7.6.3 Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Product Offerings
7.6.4 Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Pharscin Pharma Key News & Latest Developments
8 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity, Analysis
8.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity, 2018-2029
8.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Supply Chain Analysis
10.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industry Value Chain
10.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Upstream Market
10.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs in Global Market
Table 2. Top Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Type
Table 9. List of Global Tier 1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), 2024-2029
Table 16. By Sales Channel ? Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Sales Channel - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Sales Channel - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Sales Channel - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), 2018-2023
Table 20. By Sales Channel - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), 2024-2029
Table 21. By Region ? Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, (K Units), 2024-2029
Table 46. Bausch Health Company Summary
Table 47. Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Offerings
Table 48. Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Bausch Health Key News & Latest Developments
Table 50. Allergan Company Summary
Table 51. Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Offerings
Table 52. Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Allergan Key News & Latest Developments
Table 54. Sebela Pharmaceuticals Company Summary
Table 55. Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Offerings
Table 56. Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Sebela Pharmaceuticals Key News & Latest Developments
Table 58. Astellas Pharmaceuticals Company Summary
Table 59. Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Offerings
Table 60. Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Astellas Pharmaceuticals Key News & Latest Developments
Table 62. Amneal Pharms Company Summary
Table 63. Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Offerings
Table 64. Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Amneal Pharms Key News & Latest Developments
Table 66. Pharscin Pharma Company Summary
Table 67. Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Offerings
Table 68. Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Pharscin Pharma Key News & Latest Developments
Table 70. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 71. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 72. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production by Region, 2018-2023 (K Units)
Table 73. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production by Region, 2024-2029 (K Units)
Table 74. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Opportunities & Trends in Global Market
Table 75. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Drivers in Global Market
Table 76. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Restraints in Global Market
Table 77. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Raw Materials
Table 78. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Raw Materials Suppliers in Global Market
Table 79. Typical Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Downstream
Table 80. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Downstream Clients in Global Market
Table 81. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segment by Type in 2022
Figure 2. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segment by Sales Channel in 2022
Figure 3. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue in 2022
Figure 9. By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (USD/Unit), 2018-2029
Figure 13. By Sales Channel - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Sales Channel - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share, 2018-2029
Figure 15. By Sales Channel - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share, 2018-2029
Figure 16. By Sales Channel - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share, 2018-2029
Figure 23. US Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share, 2018-2029
Figure 28. Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share, 2018-2029
Figure 37. China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Region, 2022 VS 2029
Figure 54. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industry Value Chain
Figure 55. Marketing Channels
Industry Market Size
